Analysts’ Weekly Ratings Updates for Align Technology (ALGN)

A number of research firms have changed their ratings and price targets for Align Technology (NASDAQ: ALGN):

• 10/29/2026 – Align Technology had its price target lowered by Morgan Stanley from $188.00 to $175.00. They now have an “equal weight” rating on the stock.
• 10/29/2026 – Align Technology had its “hold” rating reaffirmed by Needham & Company LLC.
• 10/24/2026 – Align Technology was downgraded by Wall Street Zen from “buy” to “hold”.
• 10/22/2026 – Align Technology had its price target lowered by Mizuho from $220.00 to $200.00. They now have an “outperform” rating on the stock.
• 10/21/2026 – Align Technology had its price target lowered by Piper Sandler from $235.00 to $205.00. They now have an “overweight” rating on the stock.
• 10/21/2026 – Align Technology had its price target lowered by Piper Sandler from $235.00 to $205.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – Align Technology was downgraded by Robert W. Baird from “outperform” to “neutral”. They now have a $162.00 price target on the stock, down from $218.00.
• 10/15/2026 – Align Technology was downgraded by Zacks Research from “hold” to “strong sell”.
• 10/15/2026 – Align Technology was downgraded by Robert W. Baird from “outperform” to “neutral”. They now have a $162.00 price target on the stock, down from $218.00.
• 10/14/2026 – Align Technology had its price target lowered by Leerink Partners from $235.00 to $215.00. They now have an “outperform” rating on the stock.
• 10/9/2026 – Align Technology was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 10/9/2026 – Align Technology had its price target lowered by Stifel Nicolaus from $210.00 to $175.00. They now have a “buy” rating on the stock.
• 10/5/2026 – Align Technology had its “buy” rating reaffirmed by Raymond James Financial.
• 10/5/2026 – Align Technology was downgraded by Evercore from “outperform” to “in-line”. They now have a $155.00 price target on the stock.
• 9/25/2026 – Align Technology was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.

Align Technology Stock Performance

Shares of NASDAQ ALGN traded up $10.26 during mid-day trading on Wednesday, reaching $161.84. 264,941 shares of the company traded hands, compared to its average volume of 1,056,201. The stock has a market cap of $11.59 billion, a PE ratio of 23.56, a price-to-earnings-growth ratio of 1.67 and a beta of 1.74. The company’s fifty day moving average is $150.12 and its two-hundred day moving average is $168.59. Align Technology, Inc. has a fifty-two week low of $130.23 and a fifty-two week high of $200.43.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.77 by $0.03. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the company posted $2.61 earnings per share. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. Research analysts forecast that Align Technology, Inc. will post 9.19 earnings per share for the current year.

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.